| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5965549 | SANDOZ | Ciprofloxacin-hydrocortisone suspension |
Jun, 2015
(8 years ago) | |
| US5843930 | SANDOZ | Method of treating otitis with ciprofloxacin-hydrocortisone suspension |
Jun, 2015
(8 years ago) | |
Cipro Hc is owned by Sandoz.
Cipro Hc contains Ciprofloxacin Hydrochloride; Hydrocortisone.
Cipro Hc has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Cipro Hc are:
- US5965549
- US5843930
Cipro Hc was authorised for market use on 10 February, 1998.
Cipro Hc is available in suspension/drops;otic dosage forms.
Cipro Hc can be used as method of treating otitis.
The generics of Cipro Hc are possible to be released after 06 June, 2015.
Drugs and Companies using CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE ingredient
Market Authorisation Date: 10 February, 1998
Treatment: Method of treating otitis
Dosage: SUSPENSION/DROPS;OTIC
More Information on Dosage
CIPRO HC family patents
